CYP2C19 and myocardial infarction: Importantly, CYP2C19 loss-of-function alleles are associated with adverse cardiovascular events, including stent thrombosis, stroke, and myocardial infarction caused by reduced responsiveness to the antiplatelet drug clopidogrel [39,40].